| Literature DB >> 29113127 |
Dandan Sun1, Yang Ran2, Guanjun Wang3.
Abstract
A compact and label-free optical fiber sensor based on a taper interferometer cascaded with a fiber Bragg grating (FBG) is proposed and experimentally demonstrated for detection of a breast cancer biomarker (HER2). The tapered fiber-optic interferometer is extremely sensitive to the ambient refractive index (RI). In addition, being insensitive to the RI variation, the FBG can be applied as a temperature thermometer due to its independent response to the temperature. Surface functionalization to the sensor is carried out to achieve specific targeting of the unlabeled biomarkers. The result shows that the proposed sensor presents a low limit-of-detection (LOD) of 2 ng/mL, enabling its potentials of application in early diagnosis on the breast cancer.Entities:
Keywords: FBG; cancer biomarker; fiber taper interferometer; optical biosensor
Year: 2017 PMID: 29113127 PMCID: PMC5713131 DOI: 10.3390/s17112559
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1(a) The experimental setup including this sensor structure of the tapered fiber-optic interferometer with a fiber Bragg grating (FBG) and (b) the transmission spectrum for different RI values.
Figure 2Wavelength response of the tapered fiber-optic interferometer and FBG versus (a) RI and (b) temperature.
Figure 3(a) The scheme of surface functionalization of the tapered fiber-optic interferometer with FBG biosensors; (b–e) AFM images of the fiber surface in the conjugation process: (b) bare fiber; (c) silanization and crosslinking reaction (APTES + glutaraldehyde); (d) HER2 antibody; (e) biomarker detection).
Figure 4The real-time wavelength response of surface-functionalized biosensors in the HER2 antibody solution (10 µg/mL).
Figure 5(a) The real-time wavelength response and (b) the measured transmission spectra of surface-functionalized biosensors in the HER2 biomarker solution (10 ng/mL).
Figure 6Statistical sensing results over repeat measurement with different concentrations of HER2 biomarker and PBS buffer solution in the absence of HER2 biomarker.